The use of stable carbon isotope analysis to detect the abuse of testosterone in cattle†

Abstract

The use of stable carbon isotope analysis to detect the administration of anabolic steroids to cattle was investigated. Samples were extracted by solid-phase extraction on C₁₈ cartridges. Stable isotope ratios (¹³C:¹²C) were measured by gas chromatography-isotope ratio mass spectrometry (GC-IRMS) of the underivatised extracts. A programmed temperature vaporiser (PTV) injector was installed in the GC-IRMS system, which conferred a number of advantages. First, it allowed large volumes of sample to be injected whilst the injector liner was cool. The solvent was subsequently vented to the atmosphere prior to transfer of the sample to the GC column. Thus a significantly greater amount of sample could be presented for analysis, thereby increasing the sensitivity. Second, by this means virtually all the solvent could be removed prior to analysis. This eliminates solvent peak tailing, which can be a major problem in GC-IRMS. Finally, the PTV allowed the use of higher initial GC oven temperatures, which in turn facilitated the analysis of underivatised steroids by reducing the GC run time and improving the chromatographic peak shape. The carbon isotope composition of 5β-androstane-3α,17α-diol, the major metabolite of testosterone found in bovine bile, was measured in bile samples from untreated cattle and from cattle injected intramuscularly with testosterone or a mixture of testosterone esters. There was considerable inter-animal variation in the values obtained and there was no significant difference between samples from treated and untreated animals. However, when the isotopic composition of the metabolite was normalised with respect to that of an endogenous reference compound (cholesterol) in the same sample, the difference between treated and untreated animals became statistically significant.

References

1. P. W. Tang, W. C. Law and D. L. Crone, in Proceedings of the 15th International Conference of Racing Analysts and Veterinarians, Queensland, Australia, ed. D. E. Auer and E. Houghton, R and W Publications, Newmarket, 1996, pp. 68–72.
2. M. Donike, K. R. Bärwald, K. Klostermann, W. Schänzer and J. Zimmerman, in Testosterone in Sport: Leistung und Gesundheit, ed. H. Heck, W. Hollmann, H. Liesen and R. Rost, Deutscher Ärtze-Verlag, Cologne, 1983, pp. 293–300.
3. D. H. Catlin, D. A. Cowan, R. de la Torre, M. Donike, D. Fraisse, H. Oftebro, C. K. Hatton, B. Starcevic, M. Becchi, X. de la Torre, H. Norli, H. Geyer and C. J. Walker, J. Mass Spectrom., 1996, 31, 397.
4. M. O'Leary, Phytochemistry, 1981, 20, 553.
5. C. H. L. Shackleton, E. Roitman, A. Philips and T. Chang, Steroids, 1997, 62, 665.
6. S. Horning, H. Geyer, U. Flenker and W. Schänzer, in Recent Advances in Doping Analysis (5): Proceedings of the 15th Cologne Workshop on Dope Analysis, ed. W. Schänzer, H. Geyer, A. Gotzman and U. Mareck-Engelke, Sport und Buch Strauss, Cologne, 1998, pp. 135–148.
7. T. P. Samuels, A. Nedderman, M. A. Seymour and E. Houghton, Analyst, 1998, 123, 2401.
8. J. C. Millar and J. N. Millar, Statistics for Analytical Chemistry, Ellis Horwood, Chichester, 2nd edn., 1989.
9. T. J. Farrant, Practical Statistics for the Analytical Scientist; a Bench Guide, Royal Society of Chemistry, Cambridge, 1997.
10. V. Ferchaud, B. Le Bizec, F. Monteau, M.-P. Montrade and F. Andre, Analyst, 1998, 123, 2617.
11. M. Becchi, R. Aguilera, Y. Farizon, M. M. Flument, H. Casabianca and P. James, Rapid Commun. Mass Spectrom., 1994, 8, 304.
12. S. Horning, H. Geyer, M. Machnik, W. Schänzer, A. Hilkert and J. Oesselmann, in Recent Advances in Doping Analysis (4): Proceedings of the 14th Cologne Workshop on Dope Analysis, ed. W. Schänzer, H. Geyer, A. Gotzman and U. Mareck-Engelke, Sport und Buch Strauss, Cologne, 1997, pp. 275–283.